Bio-Rad Laboratories, Inc.

BIO · NYSE
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$488,100$403,800$434,215$470,783
Short-Term Investments$1,176,400$1,203,300$1,356,457$399,135
Receivables$452,500$489,000$494,645$423,537
Inventory$760,000$780,500$719,316$572,239
Other Curr. Assets$153,300$171,700$153,343$124,785
Total Curr. Assets$3,030,300$3,048,300$3,157,976$1,990,479
Property Plant & Equip (Net)$688,600$723,700$679,552$716,437
Goodwill$410,500$413,600$406,500$347,300
Intangibles$293,600$320,500$332,100$253,900
Long-Term Investments$4,839,200$7,698,100$8,830,892$14,387,006
Tax Assets$0$0$0$0
Other NC Assets$101,900$94,900$94,599$104,189
Total NC Assets$6,333,800$9,250,800$10,343,643$15,808,832
Other Assets$0$0$47$82
Total Assets$9,364,100$12,299,100$13,501,666$17,799,393
Liabilities
Payables$122,300$144,600$135,041$141,941
Short-Term Debt$42,900$40,900$36,801$36,924
Tax Payable$31,200$35,800$32,428$46,299
Deferred Revenue$0$0$52,211$50,852
Other Curr. Liab.$271,400$301,500$312,227$404,922
Total Curr. Liab.$467,800$522,800$568,708$680,938
LT Debt$1,331,800$1,364,600$1,351,297$186,452
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$818,000$1,475,500$1,770,481$3,064,576
Other NC Liab.$177,200$195,000$195,928$182,191
Total NC Liab.$2,327,000$3,035,100$3,317,706$3,433,219
Other Liabilities$0$0$0$0
Cap. Leases$173,100$205,900$189,933$212,373
Total Liabilities$2,794,800$3,557,900$3,886,414$4,114,157
Equity
Pref Stock$0$0$0$0
Common Stock$0$0$3$3
Retained Earnings$7,416,400$9,260,600$9,898,203$13,525,343
AOCI-$538,200-$336,000-$466,822-$175,553
Other Equity-$308,900-$183,400$183,868$335,443
Total Equity$6,569,300$8,741,200$9,615,252$13,685,236
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$9,364,100$12,299,100$13,501,666$17,799,393
Net Debt$886,600$1,001,700$953,883-$247,407
Bio-Rad Laboratories, Inc. (BIO) Financial Statements & Key Stats | AlphaPilot